Clinical Trials

NCT04925544 | ACTIVE_NOT_RECRUITING | PHASE2
13 participants

Novel Small Molecule EBNA1 Inhibitor, VK 2019, in Patients With Epstein Barr Virus (EBV)-Positive Nasopharyngeal Cancer (NPC) and Other Epstein-Barr Virus (EBV)-Associated Cancers, With Pharmacokinetic and Pharmacodynamic Correlative Studies

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-24
Start Date:
2022-01-25
Completion:
2026-06-17
Conditions
  • Nasopharyngeal Cancer
  • Epstein-Barr Virus Related Carcinoma
Interventions
  • DRUG
No Results Yet
NCT04753190 | COMPLETED | NA
84 participants

Light Timing Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-24
Start Date:
2022-08-22
Completion:
2025-05-18
Conditions
  • Chronobiology
  • Light
  • Sleep
  • Circadian Rhythm
  • Adolescence
Interventions
  • BEHAVIORAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page